The researchers who first developed these nanoparticles at the University of Seville intended to create an orally-administered, time-released cannabinoid formulation to avoid digestion of the active ingredients, target their absorption, prolong blood circulation, and provide a slow and steady release of … Read More
The post Seville to Las Vegas: GB Sciences completes cannabinoid delivery tech transfer appeared first on Dagga Magazine.